Who We Are

Dr. Barry Davis, Guy S. Parcel Chair in Public Health, Professor of Biostatistics, and Director of the Coordinating Center for Clinical Trials at The University of Texas School of Public Health, has co-authored more than 300 peer-reviewed publications. Dr. Davis has extensive experience in the leadership, design, analysis, oversight and data management of multicenter clinical trials. During the last 30 years, Dr. Davis has participated in and led numerous large-scale cardiovascular clinical trials. His research has garnered over $200 million in extramural funding. He is a Fellow of the American Statistical Association and the American Association for the Advancement of Science and has served on numerous Data Monitoring Committees.

Cindy Lemere is an Associate Professor of Neurology in the Ann Romney Center for Neurologic Diseases at Brigham & Women's Hospital and Harvard Medical School in Boston. Dr Lemere’s research focuses on using the immune system therapeutically for the treatment of Alzheimer’s disease.

Dr. Laurie Ryan is Chief of the Dementias of Aging Branch in the Division of Neuroscience at the National Institute on Aging, part of the NIH. She oversees the development, coordination and implementation of NIA’s basic and clinical Alzheimer’s disease research program. Dr. Ryan also directs the Alzheimer’s disease clinical trials research portfolio.

Eric Dishman is the director of the All of Us Research Program. He leads the agency’s efforts to build a national research program of 1 million or more U.S. participants to advance precision medicine. Eric is widely recognized as a global leader in health care innovation with specific expertise in home and community-based technologies and services for chronic disease management and independent living. Trained as a social scientist, Eric is known for pioneering innovation techniques that incorporate anthropology, ethnography and other social science methods into the development of new technologies.

Dr. Thomas Mosley is a professor in geriatric medicine and director of the MIND Center at the University of Mississippi Medical Center. He has an extensive background in clinical neuropsychology, behavioral neurology and population-based studies in neuroepidemiology. Dr. Mosley's research efforts have been largely devoted to uncovering how and why the brain changes with age. He is the principal investigator for several NIH-funded studies including the large multi-site Atherosclerosis Risk in Communities (ARIC) Neurocognitive Study.

Dr. Mary Sano is Professor of Psychiatry and the Director of the Alzheimer's Disease Research at Mount Sinai School of Medicine. She is also the Director of Research and Development at the Bronx Veterans Administration Hospital. Currently she is the director of a national multi-center study known as CLASP (Cholesterol Lowering in Alzheimer's Disease to Slow Progression). Dr. Sano is a neuropsychologist by training and has been involved in designing and conducting clinical trials for Alzheimer's disease, Parkinson's disease, and mild cognitive impairment of aging.

Abby King is a Professor of Health Research and Policy (Epidemiology) and of Medicine (Stanford Prevention Research Center). Recipient of the Outstanding Scientific Contributions in Health Psychology Award from the American Psychological Association, Dr. King's research focuses on the development, evaluation and translation of public health interventions to reduce chronic disease.

Dr. Reuben is Director, Multicampus Program in Geriatrics Medicine and Gerontology and Chief, Division of Geriatrics at the University of California, Los Angeles (UCLA) Center for Health Sciences. He sustains professional interests in clinical care, education, research and administrative aspects of geriatrics, maintaining a clinical primary care practice of frail older persons and attending on inpatient and geriatric psychiatry units at UCLA.

Consuelo H. Wilkins, MD, MSCI, is the Executive Director of the Meharry-Vanderbilt Alliance, a strategic partnership between Meharry Medical College and Vanderbilt University Medical Center. Her primary responsibilities include developing and supporting collaborative initiatives and programs in biomedical research, community engagement and interprofessional learning. She holds appointments as Associate Professor of Medicine at both Vanderbilt University Medical Center and Meharry Medical College.

Dr. Knopman is a clinical neurologist involved in research in late-life cognitive disorders, such as mild cognitive impairment and dementia. Dr. Knopman's specific interests are in the very early stages of Alzheimer's disease, in cognitive impairment due to stroke (cerebrovascular disease) and in cognitive impairment due to frontotemporal degeneration. He is involved in epidemiology, clinical trials and diagnostic studies of these disorders.